Journey Medical Corporation DERM Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 65.4%-0.7pp | 66.2%-4.0pp | 70.2%+0.8pp | 69.4%+2.9pp | 66.5%+3.7pp | |
| Efficiency | ||||||
| Asset turnover | 0.7×0.0× | 0.7×-0.1× | 0.8×0.0× | 0.8×0.0× | 0.7×0.0× | |
| Liquidity | ||||||
| Current ratio | 1.7×-0.1× | 1.8×+0.4× | 1.4×+0.2× | 1.3×-0.1× | 1.3×0.0× | |
| Leverage | ||||||
| Debt-to-equity | 0.8×0.0× | 0.8×-0.2× | 1×-0.3× | 1.3×+0.1× | 1.2×-0.1× | |
| Per Share | ||||||
| Book value per share | $1.13-13.2% | $1.30+25.3% | $1.04+25.6% | $0.83-13.3% | $0.95-3.0% | |
| Valuation | ||||||
| Market capitalization | $194.94M+20.9% | $209.22M+11.7% | $187.33M+26.0% | $148.63M+9.0% | $136.32M+66.9% | |
| Price / sales | 3×+0.2× | 3.4×+0.2× | 3.2×+0.5× | 2.6×+0.2× | 2.4×+1.0× | |
| Price / book | 6.3×-2.1× | 6.6×-0.7× | 7.2×-0.5× | 7.7×+1.4× | 6.3×+2.3× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Journey Medical Corporation's profit margins?
- Journey Medical Corporation (DERM) runs a 65.4% gross margin and a -9.8% operating margin, with a -14.8% net margin.
- Where do Journey Medical Corporation's ratios come from?
- Every ratio is computed from Journey Medical Corporation's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
